Article Text

PDF
2 year inhaled corticosteroid therapy did not prevent asthma in high risk preschool children after treatment was discontinued

Statistics from Altmetric.com


 
 Q In preschool children at high risk of asthma, does 2 year inhaled corticosteroid (IC) therapy prevent asthma after treatment is discontinued?

Clinical impact ratings GP/FP/Primary care ★★★★★★☆ Allergy & immunology ★★★★★★☆ Respirology ★★★★★★☆ Paediatrics ★★★★★★☆

METHODS

Embedded ImageDesign:

randomised controlled trial.

Embedded ImageAllocation:

{concealed*}.

Embedded ImageBlinding:

blinded (patients, healthcare providers, {data collectors, and outcome assessors}).*

Embedded ImageFollow up period:

up to 3 years.

Embedded ImageSetting:

5 clinical centres in the US.

Embedded ImagePatients:

285 children 2–3 years of age (mean age 3 y, 62% boys) who had wheezing or allergy without other clinically significant medical disorders, were at high risk of the persistence of asthma-like symptoms during their school year, had received ICs for ⩽4 months, and did not require ICs during a run in month.

Embedded ImageIntervention:

an IC (fluticasone propionate, GlaxoSmithKline), 88 µg twice daily (n = 143), …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Glossary
    BMJ Publishing Group Ltd